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ABSTRACT 
 
Understanding the interactions between bone metabolism and ovarian and plasma changes 
induced by polycystic ovary syndrome (PCOS) is essential for the comprehension of the 
pathophysiological mechanisms involving these organs. Ovarian steroids are associated with 
activities related to bone synthesis and resorption. Knowledge of the effects of the main ovarian 
steroids on the viability of osteoblasts in culture, mimicking the conditions of PCOS, can assist in 
understanding the functions of the cells in this endocrine disease that affects more than 10% of 
women of reproductive age. This work evaluated the viability of undifferentiated and differentiated 
osteoblasts in an osteogenic medium, together with phosphatase activity and mineralization of the 
extracellular matrix. The cells were cultured for different periods of time in the presence of varied 
concentrations of progesterone, testosterone, estradiol, and the combination of all three hormones. 
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The influence of the presence of fetal bovine serum in the culture medium was also determined. 
The results suggested that the culture technique employed could be used for in vitro studies of the 
effects of polycystic ovary syndrome on osteoblastic activities, before and after cell differentiation. 
 
 
Keywords: Cell culture; osteoblast; polycystic ovary syndrome; cell viability; ovarian steroids. 
 
1. INTRODUCTION 
  
Bone is a metabolically active tissue whose 
constant remodeling is dependent on the activity 
of osteoclasts for bone resorption and 
osteoblasts for synthesis of the bone matrix 
[1,2,3]. Bone remodeling involves the continuous 
removal of bone followed by the synthesis of new 
bone matrix and subsequent mineralization. It is 
required for calcium homeostasis and that repair 
of injuries associated with stress, age, and 
enodcrine interactions [4,5,6]. 
  
The sex steroids act on bone metabolism. 
Androgens are importante in the physiological 
mechanisms that control bone and muscle 
activities in women, exerting direct and/or indirect 
action on bone remodeling. Direct actions are a 
result of the binding of testosterone (T) to 
androgen nuclear receptors of bone cells. 
Indirect actions involve the conversion of T to 
estradiol (E2). This conversion requires the 
activity of the enzyme CYP19A1 (Cytochrome 
P450 19A1), present in the mitochondrial matrix 
of bone cells, which aromatizes androstenedione 
and T to estradiol [7]. Clinical evidence has found 
increased bone mass as a result of the actions of 
androgens in women with hirsutism, polycystic 
ovarian disease, and androgen-secreting ovarian 
tumor [8,9,10]. In addition, androgen deficiency 
may cause reductions in trabecular and cortical 
bone density [11]. 
  
Estrogen deficiency observed in women at 
menopause or in case of ovarian failure 
stimulates the activity of osteoclasts, causing 
increased bone resorption and decreased bone 
mineral density. Early estrogen therapy can 
minimize vertebral damage by inhibiting the 
resorption, thereby reducing the number and 
activity of osteoclasts [12]. Estrogens and 
androgens decrease the number of bone 
remodeling cycles, regulating transcription of the 
genes responsible for osteoclastogenesis, 
replication, and differentiation of mesenchymal 
cells [13]. 
  
The functional role of progestogens in the 
prevention of bone loss is less well understood 
than the roles of androgens and estrogens. 
Progesterone (P4) receptors have been identified 
in osteoclasts and osteoblasts from rats and 
humans [14]; however, it is not clear whether the 
activities of P4 in bone are direct or indirect [7]. 
The use of cyclic progestin prevents bone loss in 
women with premenopausal amenorrhea or 
subclinical ovulatory disorders [15]. 
  
Polycystic ovary syndrome (PCOS) is a 
heterogeneous endocrinopathy with adverse 
metabolic characteristics such as insulin 
resistance, hyperinsulinemia [16,17], obesity, 
anovulation, hyperandrogenism and abnormal 
ovarian morphology [17,18,19]. Approximately   
5-10% of women of reproductive age are 
affected by PCOS [20], and between 38% and 
88% of these women are overweight or obese 
[21,22,23,24]. The clinical and biochemical 
conditions of PCOS can be affected by obesity 
and are related to various metabolic events such 
as insulin resistance accompanied by 
compensatory hyperinsulinemia, increasing the 
risk of developing type 2 diabetes between 5-and 
8-fold in women with PCOS. Furthermore, the 
risks of developing hypertension and coronary 
heart disease are also higher in obese women 
with PCOS [5,21,23], while oxidative stress, 
dyslipidemia, inflammation and fibrinolysis 
increase the risk of stroke in women with PCOS 
[25]. It is estimated that the prevalence of the risk 
factors for each of these diseases is 
approximately two times higher in women with 
PCOS compared to women who do not have the 
syndrome [26]. 
  
Current treatments for PCOS are not restricted to 
reproductive approaches; they also include the 
promotion of cardiovascular health and disease 
prevention measures, with non-pharmacological 
measures including nutritional counseling and 
regular physical activity. Although the effects of 
long-term treatment strategies for PCOS have 
not been fully elucidated [27], lifestyle and dietary 
changes [28,29], regular physical exercise and 
weight loss [29,30,31,32], cessation of smoking, 
stress management, and moderate alcohol 
consumption [29] have been identified as 
important steps in the treatment of PCOS. 
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Women with PCOS have higher incidences of 
excess weight, obesity, dyslipidemia, 
hyperinsulinemia, and type II diabetes, and 
consequently present greater risk of 
cardiovascular disease and bone disorders. 
Furthermore, modification of bone metabolism 
due to hyperandrogenemia and insulin resistance 
can lead to changes in the composition of 
structures ranging from skeletal muscle to 
adipose tissue. Our laboratory is working on 
induced PCOS in animal models [33] in order to 
investigate the interrelationships among this 
important ovarian endocrine disease and 
adipose, skeletal muscle, and bone tissues [34]. 
The aim of this study was to use a cell culture 
model mimicking polycystic ovary syndrome to 
study the effects of this endocrinopathy on 
osteoblast cell viability, alkaline phosphatase 
activity, and extracellular matrix mineralization. 
  
2. MATERIALS AND METHODS 
 
2.1 Cell Culture 
  
The OSTEO-1 osteoblast line [34], obtained from 
ICB-USP, was used for the cell cultures. Our 
laboratory has already used these cells in more 
than ten experiments. Six separate cell cultures 
were used in the present study. Each well of 96-
well culture plate was inoculated with 5 x 103 
cells in 100 μL of modified Eagle’s medium 
(Sigma-Aldrich, St. Louis, MO, USA), without or 
with supplementation using 10% fetal bovine 
serum (FBS) (Sigma-Aldrich, St. Louis, MO, 
USA), penicillin (100 U/mL), and streptomycin 
(100 μg/mL) (Sigma-Aldrich, St. Louis, MO, 
USA). The cells were maintained at 37ºC under a 
humid atmosphere of 5% CO2 and 95% air for 12 
h, 24 h, 36 h (data not shown), 48 h, and 72 h 
[35]. Tests were performed to determine the 
optimum culture time, which was set at 72 h. The 
medium was replaced every 72 h and stored at -
20°C for later analysis of alkaline phosphatase. 
 
2.2 Steroid Hormones 
  
Progesterone, testosterone, and estradiol 
(Sigma-Aldrich, St. Louis, MO, USA) were used 
at different concentrations: control (without 
hormones), 10-8 M and 10-7 M (mimicking normal 
plasma concentrations in adult female rats), and 
10-6 M and 10-5 M (mimicking plasma 
concentrations in adult female rats with induced 
PCOS) [33]. The steroids were added both 
independently, and in combination (all in the 
same well) to the wells of culture plates 
containing 5 x 103 cells and 100 μL of culture 
medium, and the plates were maintained under 
the culture conditions described previously. 
 
2.3 Steroid Hormones and Osteogenic 
Differentiation 
  
Differentiation was induced using an osteogenic 
medium, following the procedures outlined by 
Maniatopoulos et al. [36]. Eagle’s medium was 
supplemented with 10% FBS, 50 μg/mL ascorbic 
acid (Sigma-Aldrich, St. Louis, MO, USA), 10-8 M 
dexamethasone (Sigma-Aldrich, St. Louis, MO, 
USA), and 10 mM β-glycerophosphate (Sigma-
Aldrich, St. Louis, MO, USA). Each well of 24-
well culture plates was inoculated with 5 x 105 
cells in 1000 μL of medium. The steroid 
hormones (P4, T, and E2) were added (alone or 
in combination) to the culture medium at the 
same concentrations described above: control 
(without hormones), 10-8 M, 10-7 M, 10-6 M, and 
10
-5
 M. The plates were incubated at 37°C under 
a humidified atmosphere of 5% CO2 and 95% air 
for 7 days and 14 days. Day 0 (zero) was taken 
to be the day on which the cells showed 
confluence (between 80% and 100%) at the 
bottom of the wells of the culture plate. The 
medium was replaced every 72 h and stored at -
20ºC for later analysis of alkaline phosphatase. 
  
2.4 Cell Viability 
  
Cell viability was assessed after 12 h, 24 h, 36 h 
(data not shown), 48 h, and 72 h of incubation. 
The MTT colorimetric assay was used, in which 
the reduction of 3- (4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide (Sigma-Aldrich, St. 
Louis, MO, USA) produces formazan (a blue 
crystalline product), by the action of 
mitochondrial dehydrogenase in viable cells. The 
quantity of these product is directly proportional 
to the blue coloration, enabling estimation of the 
number of mitochondria and consequently, the 
number of viable cells in the culture, hence 
providing and indirect measure of cell viability. 
After removal of the culture medium from the 
wells, 50 μL of MTT (0.5 mg/mL) was added to 
each well and the plate was incubated for 4 h at 
37ºC in 5% CO2. Subsequently, 100 μL of acid 
isopropanol was added to each well in order to 
fully solubilize of the precipitate formed, and the 
absorbance of the solution was measured at 570 
nm [37] using a microplate reader (Polaris, Celer 
Biotecnologia, Belo Horizonte, MG, Brazil). The 
optical density (OD) was expressed as cell 
viability using the index: cell viability (%) =     
(100 x)/control. The value for the control was 
taken as 100%, with values above and below 
100% indicating increased and decreased cell 
viability, respectively. 
 
2.5 Alkaline Phosphatase Activity
  
Alkaline phosphatase activity was determined 
from measurements of the release of 
thymolphthalein from thymolphthalein 
monophosphate, using a commercial kit (Labtest 
Diagnostica, Belo Horizonte, MG, Brazil). 
Aliquots of 50 μL of the culture medium were 
used. Absorbance was measured at 590 nm and 
the ALP activity was calculated based on the 
value for a standard. 
 
2.6 Detection and Quantification 
Biological Mineralization 
 
The method described by Gregory et al. [
used to detect extracellular matrix mineralization. 
Briefly, at the end of days 7 and 14 of the 
plate wells containing osteogenic cells were 
washed with cold PBS (Sigma-Aldrich, St. Louis, 
MO, USA) and filled with formaldehyde (10% v/v) 
(Merck, Kenilworth, NJ, USA) for 30 min. 
Subsequently, the wells were washed with 
deionized water and 1 mL of Alizarin Red 
(Sigma-Aldrich, St. Louis, MO, USA) solution 
was added. After 30 min, the excess Alizarin Red 
solution was removed, the wells were washed 
with water, and the plates were kept at room 
temperature for the wells to dry. 
  
Quantification of extracellular matrix mineraliztion 
was performed by adding 450 μL of acetic acid 
solution (10% v/v) to each well that had been 
previously stained with Alizarin Red. The plates 
were kept on a shaker for 30 min at room 
temperature, after which, 400 μL aliquots
contents of each well were transferred to 
Eppendorf tubes, followed by addition of 150 μL 
of NH4OH. Finally, the contents of the Eppendorf 
tubes were transferred to 96-well plates and the 
absorbances were measured at 405 nm
microplate reader [38]. 
 
2.7 Statistical Analysis 
  
The Sigma Stat software (Systat Software, Point 
Richmond, CA, USA) was used for statistical 
analyses. Means and standard deviation were 
calculated for each experimental variable and 
statistical significance was set up p<
collected were compared by means of one
repeated measure analysis of variance 
(ANOVA), follwed by Turkey’s multiple 
comparisions pos hoc test. 
Brancaglião et al.; AJOB, 2(3): 1-18, 2017; Article no.AJOB.34036
 
4 
 
 
of 
38] was 
culture, 
 of the 
 using a 
0.05. Data 
-way 
3. RESULTS 
 
3.1 Effects of Fetal Bovine Serum 
Culture Time on Viability 
OSTEO-1 Cells 
  
The viability of the OSTEO-1 osteoblasts (Fig. 1) 
cultured for 72 h was higher than that of the 
control group (0 h), in both the absence and 
presence of FBS. The viability of cells cultured 
for 72 h in the presence of FBS was higher than 
the cell viability of cells grown without serum for 
the same culture time. 
 
 
Fig. 1. Effects of absence (gray bars) and 
presence (black bars) of bovine fetal serum 
on viability of osteoblast – OSTEO
until 72 hours  
Results are represented as means +/
(n= 6 independent cultures). Different superscript 
lowercase letters indicate differences within the group 
among the times; # indicate differences among the 
groups. p<0.05 
 
3.2 Effects of Steroids P4, T, and E2 on 
Viability of the OSTEO
Cultured for 72 h 
  
Higher viability was shown by the cells 
maintained in culture for 72 h without FBS in the 
presence of progesterone (Fig. 2A) at 
concentrations of 10-7 M and 10-6 
viability was observed in the presence of P4 at 
10
-5
 M. In the presence of 10% FBS, cell viability 
was higher at P4 concentrations of 10
10
-7
 M. The lowest cell viability was observed for
cells cultured with P4 at 10-6 M. In comparison of 
the groups with and without s
concentrations of 10
-8
 M, 10
-5
 
(control), higher viability was found for the cells 
cultured in the presence of serum. At a
concentration of 10-6 M, the serum
group showed the highest cell viability.
 
 
 
 
 
 
 
and 
of the 
 
-1 cultured 
- SEM.  
-1 Cells 
M, while lower 
-8 M and 
 
erum, at P4 
M, and 0 M 
 P4 
-free cell 
 
The viability of the OSTEO-1 cells maintained in 
culture for 72 h in the presence of testosterone 
(Fig. 2B) and absence of serum varied according 
to the concentration used. The highest viability 
was observed with 10
-7
 M of T and the lowest cell 
viability was observed for cells cultured with 10
M of T. When the cells were cultured in the 
presence of 10% FBS, the cell viability 
decreased with increasing T concentrations. 
Comparing the groups with and without serum, 
the serum groups showed higher viability, 
compared to those cultured without serum.
  
The effect of estradiol on the viability of the 
OSTEO-1 cells is shown in Fig. 2C.
absence of 10% FBS, the highest and lowest cell 
viabilities were observed in the presence of 10
M and 10
-8
 M of E2, respectively. In the presence 
of 10% serum, the highest and lowest cell 
viabilities were observed in the presence of 10
M and 10-8 M of E2, respectively. Comparing the 
groups with and without 10% FBS, viability was 
greater for the control group and the serum 
groups at concentrations of 10-7 M and 10
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-5 
 
 In the 
-5
 
-6
 
-6 M of 
E2. In the case of the groups treated with 10
of estradiol, the serum-free group presented the 
highest viability. 
 
The viability of the OSTEO-1 cells cultivated for 
72 h was also influenced by addition of all the 
steroids together (Fig. 2D). In the absence of 
10% fetal bovine serum, cell viability was highest 
in the presence of all the hormones at 
concentrations of 10
-7
 M and lowest with all the 
hormones at concentrations of 10
fetal bovine serum was added to the culture 
medium, higher viabilities were observed in the 
cultures with hormone concentrations of 10
and 10
-7 
M, while lower cell viability was 
observed in the presence of 10
hormones. Comparison of the groups
without FBS showed that cell viability was higher 
in the groups with serum in the case of the 
control group, and the cells cultured using 
hormone concentrations of 10-8 M and 10
hormone concentrations of 10
-7
 M and 10
the viability was higher for the cells cultured 
without serum. 
(A) 
 
(B) 
 
 
 
 
 
 
 
 
-5 M 
-5 M. When 
-8 M 
-5 M of the 
 with and 
-6 M. At 
-5
 M, 
Fig. 2. Effects of different concentrations (0 (control), 10
progesterone (A), testosterone (B), estradiol (C) and all hormones together (D) on 
osteoblast – OSTEO-1 viability cultured in the absence (gray bars) and presence (black bars) 
of bovine fetal serum for 72 hours
Results are represented as means +/- 
indicate differences within the group among the concentrations; # indicate differences among the groups. p<0.05
 
3.3 Effects of Culture Time and the P4, T,
and E2 Steroid Hormones 
of Osteoblasts Cultured in 
Medium 
 
For the culture time employed here, the cells 
cultured in osteogenic medium for 14 days 
showed lower viability than those cultured for 0 
and 7 days (Fig. 3). The viability of osteo
cultured for 7 days and 14 days was influenced 
by progesterone (Fig. 4A). For cells cultured for 7 
days, greater viability was observed in the 
presence of the highest concentration (10
P4, while lower viabilities were observed for cells 
cultured at concentrations of 10
-8
 M, 10
10-6 M of P4. When the cells were cultured for 14 
days, all P4 concentrations used reduced the cell 
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(C) 
 
 
(D) 
 
 
-8
M, 10
-7
M, 10
-6
M and 10
 
SEM. (n= 6 independent cultures). Different superscript lowercase letters 
 
on Viability 
Osteogenic 
blasts 
-5 M) of 
-7
 M, and 
viability, with the concentration of 10
in the greatest reduction. 
  
When the osteoblasts were cultured for 7 days in 
the presence of testosterone (Fig. 4B),
concentrations of 10
-7
 M, 10
-6
 M, and 10
resulted in decreased cell viability. All T 
concentrations used decreased the 
osteoblasts cultured for 14 days, and the lowest 
viability was observed in the presence of 10
of the hormone. 
  
When the cells were cultured with estradiol for 7 
days, the highest and lowest viabilities were foud 
for concentrations of 10-5 M and 10
respectively (Fig. 4C). Lower viabilities were 
obtained for cells cultured for 14 days with 
 
 
 
 
 
 
 
-5
M) of 
 
 
-6 M resulting 
 hormone 
-5
 M 
viability of 
-5
 M 
-6 M, 
estradiol at concentrations at 10-7 M, 10
10
-5
 M. 
  
When the combined hormones were added to 
the osteogenic medium (Fig. 4D), concentrations
of 10-7 M, 10-6 M, and 10-5 M decreased the 
viability of cells cultured for 7 days, while cells 
cultured for 14 days showed decreased viability 
at all concentrations of the hormones
greates reduction at 10
-5
 M. 
  
Finally, for the control groups as well as
groups with individual and combined addition of 
hormones, cell viability was lower in the groups 
 
Fig. 3. Effects of culture time on viability of osteoblast cultured in osteogenic medium until 
Results are represented as means +/- 
indicate differences among the times. p<0.05
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-6 M, and 
 
 with the 
 the 
cultured for 14 days, compared to the groups 
cultured for 7 days. 
 
3.4 Effects of Culture Time and the P4, T, 
and E2 Hormones on Alkaline 
Phosphatase Activity 
  
The alkaline phosphatase activity changed 
according to the time during which
osteoblasts were cultured (Fig. 5). Higher
alkaline phosphatase activity was observed for 
the group cultured for 7 days, compared to the 
groups cultured for 0 and 14 days. 
 
 
14 days 
SEM. (n= 6 independent cultures). Different superscript lowercase letters 
 
(A) 
 
 
 
 
 
 
 
 
 
 
 
 the 
 
 
 Fig. 4. Effects of different concentrations (0 (control), 10
progesterone (A), testosterone (B), estradiol (C) and all hormones together (D) on 
osteoblast cultured in osteogenic medium for 7 days (gray bars) and 14 days (black bars)
Results are represented as means +/- 
indicate differences within the group among
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(B) 
 
 
(C) 
 
(D) 
 
 
-8M, 10-7M, 10-6M and 10
SEM. (n= 6 independent cultures). Different superscript lowercase letters 
 the concentrations; # indicate differences among the groups. p<0.05
 
 
 
 
 
 
 
-5M) of 
viability of 
 
 
Fig. 5. Alkaline phosphatase activity in osteoblast cultured in osteogenic medium for 0, 7 and 
Results are represented as means +/- 
indicate differences among the times. p<0.05
 
The groups cultured for 7 and 14 days showed 
an influence of progesterone on the alkaline 
phosphatase activity (Fig. 6A). For osteoblasts 
cultured for 7 days, the lowest alkaline 
phosphatase activity was observed with P4 at a 
concentration of 10
-7
 M. When the cells were 
cultured for 14 days, the lowest alkaline 
phosphatase activity was observed for the cells 
cultured with P4 at a concentration of
terms of the effect of culture time, the 7
osteoblast cultures showed higher alkaline 
phosphatase activity than the 14-
both without P4 (control) and with P4 at all 
concentrations except 10
-7
 M. 
 
For both culture times, the alkaline
activity was also influenced by testosterone 
(Fig. 6B). Testosterone concentrations of 10
and 10
-6
 M increased phosphatase activity in the 
cells cultured for 7 days, while lower alkaline 
phosphatase activities were observed when T 
was added at concentrations of 10
M. When the cells were cultured for 14 days, a T 
concentration of 10
-8
 M significantly decreased 
the alkaline phosphatase activity. In terms of the 
effect of the culture time, alkaline phosphatase 
activity was lower for the 14-day cultures, 
compared to the 7-day cultures. 
  
The effect of E2 on alkaline phosphatase activity 
is shown in Fig. 6C. Lower phosphatase activity 
was observed when the cells were cultured for 7 
days with E2 concentrations of 10
M. For cells cultured for 14 days, alkaline 
phosphatase activity was higher with E2 
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14 days 
SEM. (n= 6 independent cultures). Different superscript lowercase letters 
 
 10
-8
 M. In 
-day 
day cultures, 
 phosphatase 
  
-8 M 
-7
 M and 10
-5
 
-8
 M and 10
-5
 
concentrations of 10
-8
 M and 10
-5
 M. The alkaline 
phosphatase activity was higher for cells cultured 
for 7 days, compared to those cultured for 14 
days. 
 
Finally, the effects on alkaline phosphatase 
activity of adding all the hormones to the 
osteoblast cultures simultaneously are
Fig. 6D. For the 7-day cultures, 
phosphatase activity was observed for 10
concentration of the hormones. In the case o
cells cultured for 14 days, the lowest alkaline 
phosphatase activity was observed
hormones at concentrations of 10
alkaline phosphatase activity was higher for cells 
cultured for 7 days, compared to those cultured 
for 14 days. 
 
3.5 Effects of Culture Time and the P4, T, 
and E2 Hormones on 
Mineralization 
 
The osteoblasts cultured in osteogenic medium 
for 7 and 14 days showed mineralization of the 
extracellular matrix (Fig. 7). When progesterone 
was added to the medium, there were decreases
in mineralization at progesterone concentrations 
of 10-8 M, 10-7 M, and 10-6 M (Fig. 8A), for both 
culture times, compared to the cultures without 
addition of progesterone. 
 
All Tconcentrations used decreased 
mineralization of the extracellular matrix 
(Fig. 8B), irrespective of culture time, compared 
 
 
 
 
 
 
 
 shown in 
lower alkaline 
-8 M 
f 
 using the 
-8
 M. The 
Biological 
 
        
to the cultures without T. In cultures with 
testosterone at 10
-8
 M and 10
-
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6
 M, greater 
mineralization was observed for cells cultured for 
14 days, compared to those cultured for 7 
 
(A) 
 
(B) 
 
 
(C) 
 
 
 
 
 
 
 
 
days. 
Fig. 6. Effects of different concentrations (0 (control), 10
progesterone (A), testosterone (B), estradiol (C) and all hormones together (D) on alkaline 
phosphatase activity in osteoblast cultured in osteogenic medium for 7 days (gray bars) and 
Results are represented as means +/- 
indicate differences within the group among 
For cells cultured for 7 days, E2 concentrations 
of 10
-8
 M, 10
-6
 M, and 10
-5
 M decreased 
extracellular matrix mineralization, while the cells 
cultured for 14 days only showed decreased 
mineralization for E2 concentrations of 10
and 10-5 M (Fig. 8C), compared to the control 
groups. Cells cultured with E2 at 10
higher mineralization in the 14
compared to the 7-day culture. 
 
When all the hormones were added together to 
the media, the 7-day cultures showed decreased 
mineralization for hormone concentrations of 10
M, 10-7 M, and 10-6 M. The 14
showed increased in mineralization for 10
concentrations of the hormones, while decrease
mineralization was observed for all other 
hormone concentrations (Fig. 8D). Finally, 
greater mineralization was observed for cells 
cultured for 14 days using the higher hormone 
concentrations (10-6 M and 10-5 M), compared to 
those cultured for 7 days. 
 
4. DISCUSSION 
  
In studies involving the in vitro reproduction of 
biological conditions, cell culture experiments are 
used to assist in the development of models 
designed to elucidate the mechanisms of control 
of cell and tissue functions. However, it is not 
always possible to reproduce, in vitro
identical to those present in the living organism, 
mainly due to the numerous unknown functional 
mechanisms that exist in vivo. Therefore, the 
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(D) 
 
 
-8
M, 10
-7
M, 10
-6
M and 10
14 days (black bars) 
SEM. (n= 6 independent cultures). Different superscript lowercase letters 
the concentrations; # indicate differences among the groups. p<0.05
 
-6
 M 
-8
 M showed 
-day culture, 
-8
 
-day cultures 
-5
 M 
d 
, conditions 
results of in vitro experiments have to be 
analyzed in specific contexts. The results of this 
study showed that the OSTEO-1 cells remained 
viable for 72 h in culture and that the presence of 
10% FBS increased the viability of these cells. 
This viability could be associated with potential 
increases of cell differentiation and bone 
formation. Fetal bovine serum is often added to 
culture media as a supplement, because it 
contains biological components such as fatty 
acids, growth factors, amino acids, vitamins, and 
hormones, which are required for cell cultures 
performed following certain experimental 
protocols [39]. Therefore, the use of FBS in 
culture media, despite being necessary for the 
cultivation of certain cell types, can affect 
experimental results related to cell maintenance, 
division, and differentiation [40,41,42,43]. 
Furthermore, the use of this supplement
culture media may compromise experimental 
results because it is a natural substance whose 
composition can vary between samples [44]. The 
presente findings demonstrated the influence of 
FBS on cellular responses, especially in terms of 
cell viability, in the absence or presence of the 
steroid hormones. It was also found that when 
the cells were differentiated in  osteogenic 
medium, the hormones modulated cell viability, 
alkaline phosphatase activity, and mineralization 
of the extracellular matrix. 
 
When the OSTEO-1 cells were cultured with P4, 
T, and E2 (separately or in combination) in the 
absence and presence of serum, dual effects 
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were observed that were dependent on the 
concentrations of the hormones and FBS. The 
addition of P4 to the osteogenic culture medium 
resulted in stimulatory and inhibitory effects on 
cell viability for both undifferentiated [45] and 
differentiated cells. Such responses could be 
governed by factors including cell differentiation, 
specific receptors, and steroid- receptor 
interactions. The components of FBS could 
influence these responses by interfering in 
hormone-receptor interactions and activating 
and/or inhibiting intracellular signaling pathways. 
Furthermore, P4 affected alkaline phosphatase 
activity and mineralization of the extracellular 
matrix, suggesting that progesterone modulated 
the differentiation and functional activity of 
osteoblasts cultured for 14 days. The effects of 
progesterone on bone metabolism are 
controversial [46]. It has been reported to prevent 
bone loss in pre- and perimenopausal women 
[15]. The use of E2 and P4 alone, at 
concentrations of 10-10 M, was found to stimulate 
DNA synthesis and the growth of osteoblasts, 
cultured for 1 day in serum-free medium [47]. 
Furthermore, the metabolization of P4             
can generate active products that interact        
with E2 receptors and modulate bone cell activity 
[46]. 
 
In vitro studies have demonstrated that both T 
and dihydrotestosterone (DHT) modulate the 
proliferation of osteoblast progenitor cells in 
different species [48,49,50,51]. Controversial 
effects of these hormones include stimulation or 
inhibition (or neither) of alkaline phosphatase 
activity, type I collagen synthesis, synthesis and 
release of osteocalcin and mineralization of the 
extracellular matrix of bones [52,53]. In addition, 
androgens decrease apoptosis of osteoclasts 
and osteocytes [54]. Our results demonstrated 
that T influenced the viability of undifferentiated 
osteoblasts in a dose-dependent manner. 
Testosterone concentrations similar to 
physiological levels increased cell viability, while 
decreased viability was observed when 
concentrations were increased in order to mimic 
PCOS. These effects were consequences of 
direct and/or indirect interactions of T with its 
receptors present in osteoblasts. Since the cells 
were not yet differentiated, it appeared that T 
was able to influence the dynamics of 
osteoblasts in vitro prior to differentiation. In 
addition, bone engagement could be initiated 
prior to differentiation of these cells, under 
conditions similar to PCOS, in which T 
concentrations are high. The results showed that 
when the cells became differentiated in an 
osteogenic medium, the highest concentration of 
T (10
-5
 M) decreased cell viability and 
mineralization of the extracellular matrix, but did 
not change the alkaline phosphatase activity. 
Therefore, the effects of high concentrations of T 
on osteoblasts cultured for 14 days were 
indicative of a reduction in osteoblastic activity 
and impaired bone formation in vitro. 
 
Estradiol addition resulted in increased cell 
viability at a concentration of 10
-6
 M and 
decreased cell viability at 10-5 M, suggesting that 
in the case of the model studied, estradiol had a 
stimulatory effect on cell viability, prior to 
differentiation. However, after differentiation of 
the cells in an osteogenic medium, a higher E2 
concentration resulted in decreased cell viability, 
increased alkaline phosphatase activity, and 
decreased mineralization of the extracellular 
matrix. Therefore, estradiol modulated the 
activity of osteoblasts cultured for up to 14 days. 
Estrogens, especially 17β-estradiol, are 
important for bone metabolism [55]. As women 
pass through menopause, E2 levels decrease 
and there is a reduction in bone mineral density 
[56]. The interaction of E2 with its receptors ERα 
and ERβ, detected by immunohistochemistry in 
osteoblasts, osteocytes, and osteoclasts [57, 58], 
has protective effects on the bone due to a 
variety of mechanisms. These include inhibition 
of the activity of cytokines that stimulate 
osteoclast activity [59,60], inhibition of the activity 
of nuclear factor κB (NFκB) that inhibits 
osteoblast activity by modulating osteoclast 
suppresion via the relationship with 
RANKL/osteoprotegerin (OPG) [57], and 
inhibition of osteoblast apoptosis [61]. Genetic 
studies using ERα knockout mice have identified 
reduced osteoblastogenesis and expression of 
osteocalcin [62]. ERβ knockout mice have shown 
increased trabecular bone, without any changes 
in the cortical bone [63].  
 
The most interesting results in this study were 
obtained when all the steroid hormones were 
added together at higher concentrations (10
-5
 M). 
The lowest viability of the osteoblasts was 
observed under these conditions, in both the 
absence and presence of serum. The OSTEO-1 
lineage is considered to be a pre-osteoblast cell 
line [34,45], and it can be inferred that the 
exposure of these cells to high concentrations of 
P4, T, and E2 together, mimicking PCOS, may 
compromise cell differentiation and formation of 
the extracellular matrix for calcium deposition, 
hence lowering the quality of the bone tissue. 
When cells were differentiated in osteogenic 
medium, the combined hormones decreased cell 
viability in a dose-dependent manner, with the 
Fig. 7. Organic mineralization in osteoblast cultured in osteogenic medium for 0, 7 and 14 days 
Results are represented as means +/- 
indicate differences among the times. p<0.05
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lowest viability of the osteoblasts being observed 
at the highest hormone concentration (10
 
 
 
SEM. (n= 6 independent cultures). Different superscript lowercase letters 
 
(A) 
 
 
(B) 
 
 
 
 
 
 
 
 
-5
 M).
 
 Fig. 8. Effects of different concentrations (0 (control), 10
progesterone (A), testosterone (B), 
mineralization in osteoblast cultured in osteogenic m
Results are represented as means +/- 
indicate differences within the group among the concentrations; # indicate differences among the groups. p<0.05
 
However, at this concentration there were no 
changes in alkaline phosphatase activity, and 
there was an increase in bone mineralization 
after 14 days of culture. Therefore, higher 
concentrations of the combined hormones 
reduced the viability of osteoblasts and 
stimulated mineralization of the extracellular 
matrix. The sex hormone could have non
genomic effects on bone cell activity. Studies 
have shown anti-apoptotic effects of estrogens 
and androgens on osteoblasts cultured 
[64]. These hormones act in the development 
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-8M, 10-7M, 10-6M and 10
estradiol (C) and all hormones together (D) on organic 
edium for 7 days (gray bars) and 14 days 
(black bars) 
SEM. (n= 6 independent cultures). Different superscript lowercase letters 
-
in vitro 
and maintenance of the skeleton in men and 
women. In both sexes, plasma levels of E2 and 
decrease with age, contributing to reduc
mass and increased risk of fractures
vitro results obtained in this study dem
that ovarian steroids at concentrations mimicking 
those found in PCOS [33] modulated
viability and bone synthesis. We are unawared of 
any other in vitro studies that have mimicked the 
effects of ovarian steroids on the activity and 
viability of osteoblasts in a situation similar to 
PCOS. 
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5. CONCLUSION 
  
Taken together, the results demonstrated that 
the osteoblast culture model employed here 
enable evaluation on cell viability, alkaline 
phosphatase activity, mineralization of the 
extracellular matrix, together with the effects 
thereon of culture time, FBS, P4, T, and E2. 
Furthermore, according to studies in progress in 
our laboratory, this culture model can be used for 
in vitro studies of the effects of polycystic ovary 
syndrome on osteoblastic activities before and 
after cell differentiation. However, molecular and 
genomic studies are needed in order to identify 
the specific receptors and intracellular signaling 
pathways used by the ovarian steroids present in 
isolation and in combination. Additionally, studies 
using cell co-cultures are needed to elucidate the 
interactions among osteoblasts, adipocytes, and 
myocytes in metabolic and clinical situations 
similar to PCOS. 
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